Upgrade to SI Premium - Free Trial

Clene plans accelerated FDA filing for ALS drug CNM-Au8 in Q3 2026

May 4, 2026 8:01 AM
Clene Inc. (NASDAQ: CLNN) announced that the Food and Drug Administration stated the company's proposed data may support submission of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA